English  |  正體中文  |  简体中文  |  總筆數 :2837330  
造訪人次 :  39113687    線上人數 :  1120
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"su yy"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-25 / 63 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
國家衛生研究院 2025-04-18 Revisiting maternal age and child health: A nationwide birth cohort study in Taiwan Su, YY;Chen, CJ;Chen, MH;Lin, CC;Hsieh, WS;Chang, H;Chan, CK;Ho, WL;Chien, MM;Chen, PC
國家衛生研究院 2025-01-18 Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells Wang, CA;Hou, YC;Hong, YK;Tai, YJ;Shen, CH;Hou, PC;Fu, JL;Wu, CL;Cheng, SM;Hwang, DY;Su, YY;Shan, YS;Tsai, SJ
國家衛生研究院 2024-11 Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: A cross-trial, patient-level analysis D'Alessio, A;Stefanini, B;Blanter, J;Adegbite, B;Crowley, F;Yip, V;Slater, S;Fulgenzi, CAM;Celsa, C;Manfredi, GF;Pai, M;Goldin, RD;Ward, SC;Fiel, MI;Shu, DH;Su, YY;Cortellini, A;Baretti, M;Anders, R;Yarchoan, M;Hsu, C;Marron, TU;Pinato, DJ
國家衛生研究院 2024-09 TCOG T5221 trial: A phase II randomized study of gemcitabine and nab-paclitaxel in combination with S-1/LV (GASL) or oxaliplatin (GAP) as first-line treatment for metastatic pancreatic cancer Su, YY;Bai, LY;Huang, CJ;Chiu, CF;Wang, HT;Du, JS;Wang, HC;Chuang, S;Shih, YH;Lin, HC;Shan, YS;Chen, LT
國家衛生研究院 2024-08-28 Clinical outcomes and histologic findings of patients with hepatocellular carcinoma with durable partial response or durable stable disease after receiving atezolizumab plus bevacizumab Shen, YC;Liu, TH;Nicholas, A;Soyama, A;Yuan, CT;Chen, TC;Eguchi, S;Yoshizumi, T;Itoh, S;Nakamura, N;Kosaka, H;Kaibori, M;Ishii, T;Hatano, E;Ogawa, C;Naganuma, A;Kakizaki, S;Cheng, CH;Lin, PT;Su, YY;Chuang, CH;Lu, LC;Wu, CJ;Wang, HW;Rau, KM;Hsu, CH;Lin, SM;Huang, YH;Hernandez, S;Finn, RS;Kudo, M;Cheng, AL
國家衛生研究院 2024-08-02 Long-term effects on growth in preterm and small for gestational age infants: A national birth cohort study Su, YY;Chen, CJ;Chen, MH;Chang, H;Chen, CM;Lin, HC;Guo, YL;Hsieh, WS;Chen, PC
國家衛生研究院 2024-07-09 Cytoplasmic lipid droplets predict worse prognosis in diffuse large B-cell lymphoma: Next-generation sequencing deciphering lipogenic genes Wang, SH;Chiang, PM;Su, YY;Yu, YT;Chen, YP;Chen, TY;Medeiros, LJ;Chu, CY;Chen, PC;Chang, KC
國家衛生研究院 2024-06-21 A phase 1 study of biweekly nab-paclitaxel/oxaliplatin/S-1/LV for advanced upper gastrointestinal cancers: TCOG T1216 study Tsai, HJ;Yang, SH;Hsiao, CF;Kao, HF;Su, YY;Shan, YS;Yen, CJ;Du, JS;Hsu, C;Wu, IC;Chen, LT
國家衛生研究院 2024-03-25 Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer Tang, CY;Yang, SH;Li, CP;Su, YY;Chiu, SC;Bai, LY;Shan, YS;Chen, LT;Chuang, SC;Chan, DC;Yen, CJ;Peng, CM;Chiu, TJ;Chen, YY;Chen, JS;Chiang, NJ;Chou, WC
國家衛生研究院 2024-02-15 Examining arterial pulsation to identify and risk-stratify heart failure subjects with deep neural network Huang, CC;Sung, SH;Wang, WT;Su, YY;Huang, CJ;Chu, TY;Chuang, SY;Chiang, CE;Chen, CH;Lin, CC;Cheng, HM
國家衛生研究院 2024-02-15 Neuron-derived neurotensin promotes pancreatic cancer invasiveness and gemcitabine resistance via the NTSR1/Akt pathway Hung, YH;Wang, HC;Hsu, SH;Wang, LY;Tsai, YL;Su, YY;Hung, WC;Chen, LT
國家衛生研究院 2024-02-13 Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: A multicenter study in Taiwan Cheng, SM;Su, YY;Chiang, NJ;Wang, CJ;Chao, YJ;Huang, CJ;Tsai, HJ;Chen, SH;Chang, CY;Tsai, CR;Li, YJ;Yen, CJ;Chuang, SC;Chang, JSM;Shan, YS;Hwang, DY;Chen, LT
國家衛生研究院 2024-02-01 Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma- with emphasis on locoregional therapy for oligoprogression Liu, TH;Chen, SC;Rau, KM;Lu, LC;Lin, PT;Su, YY;Teng, W;Lai, SW;Yeh, RH;Kao, TM;Lee, PC;Wu, CJ;Chen, CH;Hsu, CH;Lin, SM;Huang, YH;Chen, LT;Cheng, AL;Shen, YC
國家衛生研究院 2023-Auh-15 Pancreatic cancer cell-derived semaphorin 3A promotes neuron recruitment to accelerate tumor growth and dissemination Hung, YH;Hou, YC;Hsu, SH;Wang, LY;Tsai, YL;Shan, YS;Su, YY;Hung, WC;Chen, LT
國家衛生研究院 2023-12-31 Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation Su, YY;Chiang, NJ;Chiu, TJ;Huang, CJ;Hsu, SJ;Lin, HC;Yang, SH;Yang, Y;Chou, WC;Chen, YY;Bai, LY;Li, CP;Chen, JS
國家衛生研究院 2023-11 Nivolumab plus ipilimumab (N plus I) for potentially resectable hepatocellular carcinoma (HCC): Efficacy and surgical outcome Su, YY;Lin, YJ;Hsiao, CF;Ou, DL;Chen, SC;Wang, HW;Wang, JH;Wu, YM;Lee, WC;Chou, SC;Ho, CL;Chiu, CF;Chen, LT;Shen, YS;Cheng, AL;Hsu, C
國家衛生研究院 2023-11 Single-cell RNA sequencing via Endoscopic Ultrasoundguided Fine-Needle Biopsy (EUS-FNB) Pancreatic Biopsies uncovered an aggressive subclone with a poor prognosis Su, YY;Lin, MY;Cheng, SM;Chang, WL;Yeh, CM;Yu, CC;Hsu, CW;Shan, YS;Huang, DY;Chen, LT
國家衛生研究院 2023-06-08 The experience of neoadjuvant chemotherapy versus upfront surgery in resectable pancreatic cancer. a cross sectional study Su, YY;Chao, YJ;Wang, CJ;Liao, TK;Su, PJ;Huang, CJ;Chiang, NJ;Yu, YT;Tsai, HM;Chen, LT;Shan, YS
國家衛生研究院 2023-06 Aristolochic acid (AA) exposure and telomere maintenance mechanism in liver angiosarcoma (AS) Chen, TWW;Hsu, CL;Wu, YC;Ou, DL;Su, YY;Cheng, AL;Hsu, C
國家衛生研究院 2023-06 Atezolizumab plus bevacizumab for patients with unresectable hepatocellular carcinoma and high hepatitis B viral load: Focusing on hepatic safety and viral kinetics Chen, SC;Tsou, HHS;Lee, TY;Wang, HW;Chen, YH;Wang, TE;Su, YY;Yang, S;Chiu, CF;Liu, TW;Cheng, AL;Chen, LT;Hsu, C
國家衛生研究院 2023-02-05 Real-world data validation of NAPOLI-1 nomogram for the prediction of overall survival in metastatic pancreatic cancer Su, YY;Chiang, NJ;Yang, YH;Yen, CJ;Bai, LY;Chiu, CF;Chuang, SC;Yang, SH;Chou, WC;Chen, JS;Chiu, TJ;Chen, YY;Chan, DC;Peng, CM;Chiu, SC;Li, CP;Shan, YS;Chen, LT
國家衛生研究院 2023-02 The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecan Su, YY;Chiang, NJ;Chang, JS;Wang, YW;Shen, BN;Li, YJ;Hwang, DY;Shan, YS;Chen, LT
國家衛生研究院 2023-01-30 Investigation into the content of red material in EUS-guided pancreatic cancer biopsies Lin, MY;Su, YY;Yu, YT;Huang, CJ;Sheu, BS;Chang, WL
國家衛生研究院 2022-11-15 The impact of starting dose with or without subsequent dose escalation of liposomal irinotecan on treatment outcomes in patients with metastatic pancreatic ductal adenocarcinoma Chiang, NJ;Shan, YS;Li, CP;Yang, SH;Su, YY;Chiu, SC;Bai, LY;Chuang, SC;Chan, DC;Yen, CJ;Peng, CM;Chiu, TJ;Chen, YY;Chen, JS;Chou, WC
國家衛生研究院 2022-10 Outcomes of post-immunotherapy durable responders of advanced hepatocellular carcinoma - with emphasis on locoregional therapy for oligoprogression Liu, TH;Chen, SC;Rau, KM;Lu, LC;Lin, PT;Su, YY;Teng, W;Lai, SW;Yehn, RH;Kao, TM;Lee, PC;Wu, CJ;Chen, CH;Hsu, CH;Lin, SM;Huang, YH;Chen, LT;Cheng, AL;Shen, YC

顯示項目 1-25 / 63 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目